ABCSG 12 Summary
Tamoxifen compared to anastrozole, single or in combination with zoledronat in pre-menopausal patients with breast cancer stadium I and II and hormone-receptor-positive tumor.
|Recruiting period:||06/1999 – 05/2006|
|Coordinating investigator:||Gnant, Michael; Vienna|
|Sample size:||1.250 *)|
(Click to enlarge)
*) increased to 1.800 patients, Amendment 5
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.